BNET Industries

  • Public
  • US
Dow Jones Description

Advanced Biotherapy, Inc. is a corporation organized and existing under the laws of the State of Delaware, headquartered in Woodland Hills, California with laboratories in Columbia, Maryland. The Company has demonstrated the effectiveness of its pioneering scientific strategy in the use of therapeutic antibodies by conducting investigational clinical trials treating patients suffering from AIDS, multiple sclerosis, rheumatoid arthritis, corneal transplant rejection, uveitis and certain autoimmune skin conditions, including psoriasis, and alopecia, all Th1 mediated autoimmune diseases which appear to have the same proinflammatory Th-1 activity. To date, our activities have consisted primarily of research, development and non-United States investigational human clinical trials. Such activities have resulted in accumulated losses at December 31, 2004. Our Company is developing a biologic therapeutic approach for treating a range of autoimmune diseases based on an anti-cytokine platform technology.

Contact Information

227 West Monroe

Suite 3900

Chicago, Illinois 60606

www.advancedbio...

312-701-0793

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • Lime Energy Co. Completes Previously Announced Acquisition

    3/04/09 - Merger / Acquisition - View Story

News & Analysis

Filter by

advanced biotherapy inc. - All News and Analysis

Additional Resources

  • Advanced Biotherapy, Inc. Announces Material Transactions

    - 2007-12-20

    CHICAGO -- Advanced Biotherapy, Inc. (OTCBB:ADVB) announced today that, because it believes organic dairy products are a dynamic growth industry, it has made an investment in Organic Farm Marketing, LLC ("OFM"), a Wisconsin limited liability company, which distributes dairy products. The Company acquired from OFM a convertible note...

  • Advanced Biotherapy, Inc. Announces Results of Rights Offering

    - 2007-07-23

    CHICAGO -- Advanced Biotherapy, Inc. (OTCBB: ADVB) announced today that it raised approximately $590,000 in its recently completed rights offering to stockholders of record as of June 5, 2007. The Company reported that its stockholders exercised their subscription rights to purchase 39,251,888 shares of the Company's common stock at $0.015...

  • Advanced Biotherapy, Inc. Sets Record Date for Rights Offering

    - 2007-05-25

    CHICAGO -- Advanced Biotherapy, Inc. today announced that it is setting June 5, 2007, as the record date for its rights offering. Only holders of record of the Company's stock as of the close of business on the record date will be eligible to participate in the rights offering. Generally,...

  • Advanced Biotherapy Restated 2004, 2005 and 2006 Financial Statements

    - 2007-01-12

    CHICAGO -- Advanced Biotherapy, Inc. (OTCBB:ADVB) announced today that it restated its 2004 and 2005 audited financial statements and its 2006 quarterly unaudited financial statements as follows: [TABLE OMITTED] Company President and Chief Executive Officer, Christopher W. Capps said today that "the restatements correct accounting items identified by...

Decision Makers

Name (plus bio) Position
Richard P. Kiphart Director

Board of Directors

Name (plus bio) Position
David Valentine Board of Directors

David W. Valentine has been one of our directors since May 2004. Mr. Valentine is currently the chief operating officer and a founding principal of Victory Park Capital, a private investment firm. Prior to co-founding Victory Park, Mr. Valentine served as the portfolio manager of Private Investments for a Chicago-based hedge fund as well as the Global Head Debt Private Placements for UBS Investment Bank. Prior to UBS, Mr. Valentine held several investment banking positions at ABNAMRO and Harris Nesbitt. Mr. Valentine also serves on the board of directors for Innovomed, Inc., Advanced Biotherapy, Inc. and Trustwave, Inc. He is also on the board of directors of a Washington DC-based advocacy group, the Friends of the Global Fight Against Aids, Tuberculosis, and Malaria. Mr. Valentine is the son-in-law of Richard Kiphart, our chairman.

Organization Position Status
Victory Park Founder Current
Ambirontrustwave Limited Board of Directors Current
Lime Energy Co. Board of Directors Current
Advanced Biotherapy, Inc. Board of Directors Current
First Data Corporation Former
ABN AMRO Holding N.V. Former
Lime Energy Co. Chair Former
Harvard Business School M.B.A. Former
Dartmouth College B.A. Former
Organization Position Status
SAFLINK Corporation Lead Independent Director Current
William Blair Capital Partners Head Current
William Blair & Company, L.L.C. Head of the Corporate Finance Department Current
Investor Annex Head of William Blair & Company's Corporate Finance Department Current
William Blair & Company LLC Principal Current
Maximum Performance Group Chairman Current
Lime Energy Co. Chairman of the Board Former
SAFLINK Corporation Director Co-Chairman of the Board, Lead Independent Director Current
Emmi Solutions, LLC Board of Directors Current
SAFLINK Corporation Director Current
Nature Vision, Inc. Director Current
Advanced Biotherapy, Inc. Director Current
Data, Inc. Board of Directors Current
First Data Corporation Director Former
Lime Energy Co. Board of Directors Former
Harvard Business School MBA Former
Dartmouth College B.A. Former
advertisement
Glass Door

Pharma Industry Companies

Company Employer Rating
Pfizer 3.0
advertisement